Journal
NEUROCHEMICAL RESEARCH
Volume 47, Issue 2, Pages 394-408Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11064-021-03453-4
Keywords
Brain; Ischemia; Reperfusion; Hyperglycemia; Inflammation; Oxidative stress
Categories
Funding
- General Research Fund, Research Grants Council
- University of Hong Kong Seed Funding Programme for Basic Research [201811159123]
- Boston University School of Medicine Wing Tat Lee Endowment
- Government of the Hong Kong Special Administrative Region [17112919]
Ask authors/readers for more resources
alpha-Melanocyte-stimulating hormone (alpha-MSH) has neuroprotective effects against ischemia/reperfusion (I/R) induced brain damage in experimental stroke associated with hyperglycemia, reducing neuron death, inflammation, and oxidative stress. The use of alpha-MSH analogues may be a potential therapeutic strategy for diabetic stroke.
Persons with type 1 diabetes have an increased risk of stroke compared with the general population. alpha-Melanocyte-stimulating hormone (alpha-MSH) is a neuropeptide that has protective effects against ischemia/reperfusion (I/R) induced organ damages. In this study, we aimed to investigate the neuroprotective role of this peptide on I/R induced brain damage after experimental stroke associated with hyperglycemia using C57BL/6J Ins2(Akita/+) mice. Experimental stroke was induced by blocking the right middle cerebral artery for 2 h with reperfusion for 2 and 22 h, respectively using the intraluminal method. Animals were treated intraperitoneally with or without alpha-MSH at 1 h after ischemia and 1 h after reperfusion. Significantly higher survival rate and lower neurological scores were recorded in animals injected with alpha-MSH. Similarly, neuron death, glial cells activation as well as oxidative and nitrosative stress were significantly decreased in alpha-MSH treated group. Relative intensities of matrix metallopeptidases 9, cyclooxygenase 2 and nuclear factor-kappa B were significantly decreased while intensities of Akt, heme oxygenase (HO) 1, HO-2 and B-cell lymphoma 2 were significantly increased after alpha-MSH treatment. In addition, gene expressions of monocarboxylate transporter (MCT) 1, MCT-2 and activity-regulated cytoskeleton-associated protein were significantly higher in brain samples treated with alpha-MSH, suggesting this peptide may have role in neuron survival by an involvement of lactate metabolism. In conclusion, alpha-MSH is neuroprotective under hyperglycemic condition against I/R induced brain damage by its anti-inflammatory, anti-oxidative and anti-apoptotic properties. The use of alpha-MSH analogues may be potential therapeutic agents for diabetic stroke.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available